United States Influenza Vaccines Market Research 2025 Featuring Sanofi Pasteur, GSK, Seqirus, AstraZeneca - Size, Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2033
January 16, 2025 04:10 ET
|
Research and Markets
Dublin, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The "United States Influenza Vaccines Market Report 2025: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to...
Travel Vaccines Industry Forecast 2024-2032, Featuring Strategic Analysis of GlaxoSmithKline, Merck & Co, Sanofi, Pfizer, CSL Limited, Bavarian Nordic, Roche, Abbott Labs, AstraZeneca, Janssen Pharma & More
January 10, 2025 06:43 ET
|
Research and Markets
Dublin, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The "Travel Vaccines Market Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The global travel vaccines market attained a...
$960 Mn Vaccine Adjuvants Market by Product, ROA, Disease Type, Vaccine - Global Forecast to 2029 with GSK, Seppic, Croda, SPI Pharma, Phibro Animal Health, Agenus, Dynavax Technologies Dominating
January 08, 2025 09:32 ET
|
Research and Markets
Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The "Vaccine Adjuvants Market by Product, ROA, Disease Type, Vaccine, Type - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's...
mRNA Vaccines and Therapeutics Industry Forecast to Generate Over $72 Billion in Revenues by 2032 - Breakdown by Vaccine Type, Treatment Type, Vaccine Manufacturing, Application, End-user, and Region
December 11, 2024 04:18 ET
|
Research and Markets
Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "mRNA Vaccines and Therapeutics Market by Vaccine Type, Treatment Type, Vaccine Manufacturing, Application, End-user, and Region 2024-2032" report has...
Self Amplifying RNA Vaccines Patent Landscape and Forecast Report 2024-2032, Featuring Gentech, Novartis, Human Genome Sciences, Immatics Biotechnologies and Broad Institute
November 12, 2024 11:25 ET
|
Research and Markets
Dublin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The "Self Amplifying RNA Vaccines Patent Landscape Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The self...
HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress
November 07, 2024 08:00 ET
|
HilleVax, Inc.
$189.3 million of cash, cash equivalents and marketable securities as of September 30, 2024 The company is exploring the potential for continued development of its norovirus vaccine candidates in...
United States Influenza Vaccines Market Report 2025: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts 2019-2023 & 2024-2033
October 29, 2024 10:59 ET
|
Research and Markets
Dublin, Oct. 29, 2024 (GLOBE NEWSWIRE) -- The "United States Influenza Vaccines Market Report 2025: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to...
2024 Research | Vaccine Delivery Devices Market Poised for Remarkable Growth, Expected to Reach $9.45 Billion by 2028
October 04, 2024 09:06 ET
|
Research and Markets
Dublin, Oct. 04, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Delivery Devices Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. In a significant development for the...
Pneumococcal Vaccine Research Report 2024: Market Expected to Reach $12.932 Billion by 2029
September 25, 2024 10:22 ET
|
Research and Markets
Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "Pneumococcal Vaccines Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.The global pneumococcal...
Pneumococcal Vaccine Market Research 2024-2030: Prevnar 13, VAXNEUVANCE, PNEUMOSIL Size, Share & Trends Analysis
September 06, 2024 07:17 ET
|
Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Global Pneumococcal Vaccine Market Size, Share & Trends Analysis Report by Vaccine Type, Product (Prevnar 13, VAXNEUVANCE, PNEUMOSIL), End-use...